Pharmaceutical companies operate in an industry where increasing regulatory scrutiny is the norm. So it is understandable when a pharmaceutical company is about to initiate a drug recall, regulators may seem like the enemy—ready to pounce at the slightest misstep. But the reality is typically quite different, and assuming an adversarial perspective from the start…